Literature DB >> 1956031

The clinical presentation of malignant hypertension in Nigerians.

S Kadiri1, B O Olutade.   

Abstract

To document the clinical presentation of malignant accelerated hypertension in Nigerians, 56 patients were studied between 1987 and 1989 (30 months). Age range was 16 to 55 years with 59% in the range of 30-49 years; 47 were male. Mean systolic and diastolic blood pressures were 217 mmHg and 146 mmHg, respectively. Thirty patients had grade III and 26 grade IV hypertensive retinopathy. Mean body mass index was only 22.4 in the 21 patients who had no evidence of fluid retention. Seventy-five percent of patients had no awareness of hypertension. Essential hypertension accounted for 66%, chronic renal disease 32% and renal artery stenosis 2% of cases. The most common clinical features were headaches (80%), fatigue (68%), oliguria (52%), heart failure (46%), weight loss (41%), and poor vision (21%). Multiple symptoms were common and 24 patients had both renal and cardiac failure. Laboratory features included microscopic haematuria (100%) and proteinuria (100%). In 37 patients with essential hypertension, renal failure was a complication in 60%. Microangiopathic haemolytic anaemia was present in 23 patients. In addition to eight deaths from renal failure in the acute stage, 23 of these patients required long-term dialysis. Thus, malignant accelerated hypertension was associated with high morbidity, especially renal failure; it primarily afflicted patients in their prime years. Known survival at one year was 37.5%, but some patients were lost to follow-up.

Entities:  

Mesh:

Year:  1991        PMID: 1956031

Source DB:  PubMed          Journal:  J Hum Hypertens        ISSN: 0950-9240            Impact factor:   3.012


  7 in total

1.  Differentiating malignant hypertension-induced thrombotic microangiopathy from thrombotic thrombocytopenic purpura.

Authors:  Nabin Khanal; Sumit Dahal; Smrity Upadhyay; Vijaya Raj Bhatt; Philip J Bierman
Journal:  Ther Adv Hematol       Date:  2015-06

2.  Thrombotic microangiopathy as a complication in a patient with focal segmental glomerulosclerosis.

Authors:  Kerstin Benz; Kerstin Amann; Katalin Dittrich; Jörg Dötsch
Journal:  Pediatr Nephrol       Date:  2007-09-20       Impact factor: 3.714

3.  Awareness, Treatment, and Control of Hypertension in Primary Health Care and Secondary Referral Medical Outpatient Clinic Settings at Enugu, Southeast Nigeria.

Authors:  Chioli Chijioke; Raphael Anakwue; Teddy Okolo; Esther Ekwe; Chukwuemeka Eze; Charles Agunyenwa; Nnamdi Nwosu; Christopher Amah; Kenneth Nwadike; Udunma Chijioke
Journal:  Int J Hypertens       Date:  2016-12-06       Impact factor: 2.420

4.  Characteristics and Outcome of Biopsy-proven Malignant Hypertension with Severe Kidney Injury: A Retrospective Study.

Authors:  Satish Haridasan; P S Priyamvada; Dhanin Puthiyottil; Arjun Pradeep; Sreejith Parameswaran; B H Srinivas; Rajesh Nachiappa Ganesh
Journal:  Indian J Nephrol       Date:  2021-04-10

5.  Malignant hypertension: does this still exist?

Authors:  Magdalena Domek; Jakub Gumprecht; Gregory Y H Lip; Alena Shantsila
Journal:  J Hum Hypertens       Date:  2019-10-21       Impact factor: 3.012

6.  Long-term renal outcome in patients with malignant hypertension: a retrospective cohort study.

Authors:  Fouad Amraoui; Sarah Bos; Liffert Vogt; Bert-Jan van den Born
Journal:  BMC Nephrol       Date:  2012-07-30       Impact factor: 2.388

7.  Anti-hypertensive medicines prescribing for medical outpatients in a premier teaching hospital in Nigeria: a probable shift of paradigm.

Authors:  Unyime I Eshiet; Kazeem B Yusuff
Journal:  Pharm Pract (Granada)       Date:  2014-03-15
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.